Home » Stocks » OLK

Olink Holding AB (publ) (OLK)

Stock Price: $37.60 USD -0.15 (-0.40%)
Updated Apr 9, 2021 4:00 PM EDT - Market closed
Market Cap 4.47B
Revenue (ttm) 54.07M
Net Income (ttm) -6.78M
Shares Out 119.01M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 9
Last Price $37.60
Previous Close $37.75
Change ($) -0.15
Change (%) -0.40%
Day's Open 37.50
Day's Range 37.20 - 38.35
Day's Volume 109,702
52-Week Range 28.97 - 42.20

News

Hide News

Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the pricing of its...

2 weeks ago - GlobeNewswire

Olink Holding, which provides a platform of proteome analysis products for biomedical research, filed on Wednesday with the SEC to raise up to $100 million in a US initial public offering.

1 month ago - NASDAQ

Olink Holding AB (publ) has filed to go public with an IPO on the NASDAQ.

1 month ago - SEC

About OLK

Our purpose is to enable and accelerate the field of proteomics by providing a platform of products and services that are deployed across major biopharmaceutical companies and leading clinical and academic institutions, to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. We support 30 of the world’s largest 40 biopharmaceutical companies by 2019 revenue, including all of the largest 19, and many leading academic institutions. Our current offering is based on our pr... [Read more...]

Industry
Diagnostics & Research
IPO Date
Mar 25, 2021
CEO
Jon Heimer
Employees
214
Stock Exchange
NASDAQ
Ticker Symbol
OLK
Full Company Profile

Financial Performance

In 2020, Olink Holding's revenue was $54.07 million, an increase of 29.68% compared to the previous year's $41.69 million. Losses were -$6.78 million, -62.08% less than in 2019.

Financial Statements